Incorrect drug administration duration adverse event reports that record this term

Kind of term: MedDRA preferred term

What a report is

A report is not proof that the drug was the cause of the event.

FDA says:

Adverse event reports submitted to FDA do not undergo extensive validation or verification. Therefore, a causal relationship cannot be established between product and reactions listed in a report. While a suspected relationship may exist, it is not medically validated and should not be the sole source of information for clinical decision making or other assumptions about the safety or efficacy of a product. Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.
Source: openFDA, Drug Adverse Event Overview, section "Responsible use of the data". The site read the page on 2 Oct 2026. The data have the reports that FDA received through 30 Jun 2026.

FDA also says:

There is no certainty that the reported event (adverse event or medication error) was actually due to the product. FDA does not require that a causal relationship between a product and event be proven, and reports do not always contain enough detail to properly evaluate an event. The information in these reports has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of these events.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated.
Source: openFDA, Response of the drug event API (meta.disclaimer). The site read the page on 2 Oct 2026.

Not medical advice. This site counts what was reported to FDA. Questions about a medicine or device belong with a pharmacist or clinician.

Reports on file

From April 2005 to September 2018, FDA received 28,151 adverse event reports that record the MedDRA preferred term Incorrect drug administration duration. The person who codes a report selects the term that agrees best with the description of the reporter.

FDA received 0 reports in the 12 months to June 2026 and 0 in the 12 months before. FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases.

The number of people who use the product is not in the data. A count is not a rate.

MedDRA

The Medical Dictionary for Regulatory Activities. The person who codes a report selects the preferred term that agrees best with the description of the reporter. FDA does not publish the description.

Data version

openFDA FAERS release of 1 Oct 2026. Reports received through 30 Jun 2026.

Drugs in these reports

The table has the 129 drug pages with 25 or more reports that record this term. The rows are in order of name. A drug page with fewer reports for this term is not in the table. The counts are the counts that the site keeps for each reaction term, and a count can be lower than the count of FDA.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.
Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of 11 Mar 2026. The site read the page on 2 Oct 2026.

Drugs that the reports with the term Incorrect drug administration duration name as a suspect product, in order of name
Drug	Class	Reports with this term
Abreva	Non-Standardized chemical allergen	803
Acetaminophen		98
Acetylsalicylic Acid		33
Advil	Nonsteroidal anti-inflammatory drug	30
Alendronate sodium	Bisphosphonate	43
Aleve	Nonsteroidal anti-inflammatory drug	1,497
Aleve Caplet		638
Aleve Caplet/Tablet Midol Extended Relief Caplet		225
Aleve liquid gels	Nonsteroidal anti-inflammatory drug	75
Aleve Liquid Gels 220 Mg		55
Aleve PM	Histamine-1 receptor antagonist	97
Ambien	gamma-Aminobutyric acid A receptor positive modulator	37
Arixtra	Factor Xa inhibitor	188
Aspirin	Nonsteroidal anti-inflammatory drug	39
Azasite	Macrolide antimicrobial	58
Bayer aspirin extra strength	Nonsteroidal anti-inflammatory drug	27
Bayer Aspirin Regimen Adult Low Strength		35
Bayer genuine aspirin	Nonsteroidal anti-inflammatory drug	34
Bayer Genuine Aspirin Original Strength		46
Bayer Low Dose	Nonsteroidal anti-inflammatory drug	53
Bufferin		43
Chantix	Partial cholinergic nicotinic agonist	25
Clobetasol propionate	Corticosteroid	35
Clofazimine	Antimycobacterial	25
Daytrana	Central nervous system stimulant	1,191
Delamanid		28
Delsym (Dextromethorphan)	Expectorant	45
Dexilant	Proton pump inhibitor	66
Diclofenac	Nonsteroidal anti-inflammatory drug	30
Diclofenac sodium	Nonsteroidal anti-inflammatory drug	28
Duragesic		99
Duragesic-100		455
Durogesic		30
Durotep Mt		63
Enbrel	Tumor necrosis factor blocker	45
Entyvio	Integrin receptor antagonist	28
Etonogestrel Implant- Unknown		49
Excedrin	Central nervous system stimulant	49
Excedrin Extra Strength	Central nervous system stimulant	183
Exelon	Cholinesterase inhibitor	68
Famotidine	Histamine-2 receptor antagonist	32
Fentanyl	Opioid agonist	49
Fentanyl Transdermal System		358
Fentanyl-100		78
Flonase	Histamine-1 receptor antagonist	42
Flonase Allergy Relief		26
Forteo	Parathyroid hormone analog	280
Fosamax	Bisphosphonate	60
Guaifenesin	Expectorant	53
Hetlioz	Melatonin receptor agonist	61
Humalog	Insulin analog	279
Humalog Kwikpen	Insulin analog	25
Humalog Mix75/25	Insulin analog	78
Humira		226
Humulin 70/30	Insulin	31
Humulin N	Insulin	77
Humulin R	Insulin	51
Ibuprofen	Nonsteroidal anti-inflammatory drug	98
Imodium Multi-Symptom Relief		29
Implanon		1,216
Incivek		77
Innohep		39
Ketorolac		43
Lamisil		47
Lansoprazole	Proton pump inhibitor	89
Lexiscan(r) (regadenoson)		51
Lidocaine patch	Amide local anesthetic	33
Lidoderm	Amide local anesthetic	26
Loperamide hydrochloride	Opioid agonist	186
Metoclopramide	Dopamine-2 receptor antagonist	2,476
Metoclopramide hydrochloride	Dopamine-2 receptor antagonist	708
Minivelle	Estrogen	136
Minoxidil	Arteriolar vasodilator	33
MiraLAX	Osmotic laxative	2,166
Mirena	Progestin	39
Mucinex	Expectorant	307
Mucinex D	Expectorant	31
Mucinex DM	Expectorant	74
Mucinex Dm Maximum Strength	Expectorant	83
Mucinex Maximum Strength	Expectorant	183
Naproxen sodium	Nonsteroidal anti-inflammatory drug	47
Nexium	Proton pump inhibitor	105
Nexium 24HR	Proton pump inhibitor	42
Nexplanon	Progestin	1,042
Niaspan		43
Nicoderm Cq	Cholinergic nicotinic agonist	55
Nicorette	Cholinergic nicotinic agonist	232
Nicotine	Cholinergic nicotinic agonist	222
Nicotine polacrilex	Cholinergic nicotinic agonist	55
Nicotine transdermal system patch	Cholinergic nicotinic agonist	105
Nicotinell		31
NuvaRing	Estrogen	1,016
Omeprazole	Proton pump inhibitor	58
Ortho Evra		26
Otrivin		68
Oxymetazoline hydrochloride	Vasoconstrictor	39
Oxytrol for Women	Cholinergic muscarinic antagonist	106
Pegasys	Interferon alpha	37
Phenylephrine hcl	alpha-1 adrenergic agonist	32
Picato		537
Picato Gel		50
Polyethylene glycol 3350	Osmotic laxative	621
Prevacid	Proton pump inhibitor	74
Prevacid 24 HR	Proton pump inhibitor	269
Prilosec	Proton pump inhibitor	38
Prilosec OTC	Proton pump inhibitor	455
Ranitidine hydrochloride	Histamine-2 receptor antagonist	141
Reglan	Dopamine-2 receptor antagonist	698
Regranex		118
Ribavirin	Nucleoside analog antiviral	75
Samsca	Vasopressin V2 receptor antagonist	176
Sandostatin LAR Depot		25
Soliris	Complement inhibitor	34
Sovaldi	Hepatitis C virus nucleotide analog NS5B polymerase inhibitor	25
Supprelin	Gonadotropin releasing hormone receptor agonist	65
Tasigna	Kinase inhibitor	66
Teriparatide	Parathyroid hormone analog	36
Testosterone cypionate	Androgen	38
Transderm Scop	Anticholinergic	51
Tylenol	Expectorant	41
Tylenol 8 Hr Arthritis Pain		46
TYLENOL Extra Strength		140
Xarelto	Factor Xa inhibitor	34
Zantac		366
Zantac 150		42
Zecuity		242
Zegerid OTC	Proton pump inhibitor	75
Zyrtec	Histamine-1 receptor antagonist	35
Zyrtec-D	Histamine-1 receptor antagonist	36

The page of each drug has the count of each reaction term in its reaction lookup.

Drug classes in these reports

The table has the 47 pharmacologic classes with 25 or more reports that record this term. The rows are in order of name.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.
Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of 11 Mar 2026. The site read the page on 2 Oct 2026.

Pharmacologic classes of the drugs that the reports with the term Incorrect drug administration duration name, in order of name
Class	Reports with this term
Amide local anesthetic	64
Androgen	40
Anticholinergic	65
Antimycobacterial	43
Arteriolar vasodilator	37
Atypical antipsychotic	26
Azole antifungal	28
Benzodiazepine	37
Bisphosphonate	115
Central nervous system stimulant	1,440
Cholinergic muscarinic antagonist	109
Cholinergic nicotinic agonist	695
Cholinesterase inhibitor	70
Complement inhibitor	34
Corticosteroid	133
Dopamine-2 receptor antagonist	3,882
Estrogen	1,222
Expectorant	819
Factor Xa inhibitor	237
Fluoroquinolone antibacterial	36
gamma-Aminobutyric acid A receptor positive modulator	45
Gonadotropin releasing hormone receptor agonist	65
Hepatitis C virus NS5A inhibitor	38
Hepatitis C virus nucleotide analog NS5B polymerase inhibitor	25
Histamine-1 receptor antagonist	227
Histamine-2 receptor antagonist	230
Insulin	165
Insulin analog	418
Integrin receptor antagonist	33
Interferon alpha	37
Kinase inhibitor	78
Macrolide antimicrobial	76
Melatonin receptor agonist	61
Non-Standardized chemical allergen	803
Nonsteroidal anti-inflammatory drug	1,959
Nucleoside analog antiviral	75
Opioid agonist	316
Osmotic laxative	2,807
P2Y12 platelet inhibitor	41
Parathyroid hormone analog	316
Partial cholinergic nicotinic agonist	25
Progestin	1,086
Proton pump inhibitor	1,300
RANK ligand inhibitor	27
Tumor necrosis factor blocker	87
Vasoconstrictor	54
Vasopressin V2 receptor antagonist	193

A class with many reports in all has many reports for almost every term.

Reports by month

Reports that record Incorrect drug administration duration, by month, five years to June 2026

FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases.

Patients in these reports

Age of the patient in the reports that record Incorrect drug administration duration
Age	Reports	Share
Under 2	71	0.3%
2 to 11	714	2.5%
12 to 17	307	1.1%
18 to 44	2,969	10.5%
45 to 64	3,528	12.5%
65 to 74	2,396	8.5%
75 and over	3,368	12%
Age not given	14,798	52.6%

Sex of the patient in the reports that record Incorrect drug administration duration
Sex	Reports	Share
Female	18,144	64.5%
Male	8,557	30.4%
Unknown or not given	1,450	5.2%

Age and sex are as the report gives them. 90.4% of these reports give the United States as the country.

Terms near this one

These are the next terms in the A to Z list. The links are for navigation.

Official pages

MedWatch Online Voluntary Reporting FormThe online form of FDA for a voluntary report.
MedWatch: The FDA Safety Information and Adverse Event Reporting ProgramThe page of the FDA program that receives reports about drugs and devices.
FDA Adverse Event Monitoring System (AEMS) Public DashboardThe public dashboard of FDA for adverse event reports on drugs and biologics.

The site checked these addresses on 2 Oct 2026. The links open in a new tab.

Cite this page

Reported Reactions. Incorrect drug administration duration: adverse event reports that record this term. https://reportedreactions.com/reaction/incorrect-drug-administration-duration/ Source: U.S. Food and Drug Administration, openFDA Drug Adverse Event (FAERS) files, release of 1 Oct 2026. Reports received through 30 Jun 2026.

Where the data come from

The counts come from the openFDA Drug Adverse Event (FAERS) bulk files, release of 1 Oct 2026. The files have the reports that FDA received through 30 Jun 2026. A drug name is the name on the report. The site matches it to a brand name or a generic name of the National Drug Code Directory of 2 Oct 2026. A class is the pharmacologic class (EPC) of the FDA label.

The count has the reports with each spelling of one MedDRA preferred term. The site does not publish a report narrative, a lot number, a detail of a patient or the identity of a reporter. The record of FDA is the authority. See how the site counts reports, the data sources and the corrections page.

Questions

What does Incorrect drug administration duration mean in an adverse event report?

It is a MedDRA preferred term. FDA codes the description of a reporter with the MedDRA dictionary. The openFDA files do not have the description itself, and this site does not show it.

Does a drug in the table mean that the drug was responsible for this reaction?

No. FDA says:

No individual drug is connected to any individual reaction.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

When a report lists multiple drugs and multiple reactions, there is no way to conclude from the data therein that a given drug is responsible for a given reaction.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

What does this page tell a person who has this symptom?

This page gives counts of reports. It cannot assess a person. A pharmacist or a clinician can assess a person.

If this is a medical emergency, please call 911.
Source: FDA, MedWatch Online Voluntary Reporting Form. The site read the page on 2 Oct 2026.

To the top of the page